Premium
Non‐alcoholic fatty liver disease satisfactorily treated with traditional Japanese kampo medicine
Author(s) -
Shimada Yutaka,
Fujimoto Makoto,
Nogami Tatsuya,
Watari Hidetoshi,
Kitahara Hideyuki,
Misawa Hiroki,
Kimbara Yoshiyuki
Publication year - 2018
Publication title -
traditional and kampo medicine
Language(s) - English
Resource type - Journals
ISSN - 2053-4515
DOI - 10.1002/tkm2.1083
Subject(s) - kampo , medicine , fatty liver , traditional medicine , aspirin , gastroenterology , disease , alternative medicine , pathology
Case An obese 17‐year‐old male patient with right hemiparesis secondary to cerebral infarction presented for kampo treatment. The hemiparesis and resultant lack of exercise had led to an increase in bodyweight. Serum alanine aminotransferase (ALT) was elevated and abdominal ultrasound identified fatty liver. The patient was diagnosed with non‐alcoholic fatty liver disease (NAFLD). Aspirin and tocopherol acetate (vitamin E), previously prescribed, were continued, and kampo medicines were prescribed. Outcome Two years and 6 months after the initial visit, we prescribed keishikashakuyakuto ( Gui Zhi Jia Shao Yao Tang ) extract, in addition to keishibukuryogan ( Gui Zhi Fu Ling Wan ) extract. Thereafter, serum ALT gradually decreased, despite no significant change in bodyweight or blood platelet count. Conclusion Kampo medicine may be effective for the treatment of NAFLD.